Metropolis Healthcare Launches Centre of Genomics for Precision Diagnostics in India

• Metropolis Healthcare launched a Centre of Genomics to expand precision diagnostics, molecular testing, and genomic research in India.
• The center will be supported by two CAP-accredited genomics laboratories in Mumbai and Delhi NCR.
• It will focus on high-impact clinical areas like oncology, reproductive health, neurology, transplant immunology, and rare diseases.
• Metropolis plans to expand its genomic portfolio from 220 to over 500 advanced tests in the next 2-3 years.
• The initiative includes deploying Illumina’s NovaSeq X Series sequencing platform for enhanced genomic analysis and research.

Why It Matters: Metropolis Healthcare's new Centre of Genomics aims to revolutionize precision diagnostics across India.